{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:08:07Z","timestamp":1791176887081,"version":"4.1.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,21]]},"DOI":"10.1093\/jnci\/djs395","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T09:38:02Z","timestamp":1351503482000},"page":"1712-1723","source":"Crossref","is-referenced-by-count":125,"title":["Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model\u2013Based Analysis"],"prefix":"10.1093","volume":"104","author":[{"given":"Nicolas","family":"Van de Velde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Boily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Mayrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich V.","family":"Kliewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Laprise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal\u00eda","family":"Malag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,27]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology."},{"key":"key\n\t\t\t\t20170521020849_CIT0002","author":"Health Canada","year":"2011"},{"issue":"6","key":"key\n\t\t\t\t20170521020849_CIT0003","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis."},{"issue":"10","key":"key\n\t\t\t\t20170521020849_CIT0004","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/000348949510401002","article-title":"Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis","volume":"104","author":"Pou","year":"1995","journal-title":"Ann Otol Rhinol Laryngol."},{"issue":"4","key":"key\n\t\t\t\t20170521020849_CIT0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"key\n\t\t\t\t20170521020849_CIT0006","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med."},{"issue":"4","key":"key\n\t\t\t\t20170521020849_CIT0007","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control."},{"issue":"7","key":"key\n\t\t\t\t20170521020849_CIT0008","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170521020849_CIT0009","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"9686","key":"key\n\t\t\t\t20170521020849_CIT0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)\u201316\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet."},{"issue":"19","key":"key\n\t\t\t\t20170521020849_CIT0011","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med."},{"issue":"7","key":"key\n\t\t\t\t20170521020849_CIT0012","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis."},{"issue":"7","key":"key\n\t\t\t\t20170521020849_CIT0013","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326 years","volume":"199","author":"Wheeler","year":"2009","journal-title":"J Infect Dis."},{"key":"key\n\t\t\t\t20170521020849_CIT0014","year":"2010"},{"issue":"11","key":"key\n\t\t\t\t20170521020849_CIT0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"issue":"26","key":"key\n\t\t\t\t20170521020849_CIT0016","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine."},{"issue":"3","key":"key\n\t\t\t\t20170521020849_CIT0017","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ygyno.2009.01.011","article-title":"Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses","volume":"115","author":"David","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170521020849_CIT0018","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect."},{"issue":"5","key":"key\n\t\t\t\t20170521020849_CIT0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/11539960-000000000-00000","article-title":"Modelling the epidemiology of infectious diseases for decision analysis: a primer","volume":"29","author":"Jit","year":"2011","journal-title":"Pharmacoeconomics."},{"issue":"29","key":"key\n\t\t\t\t20170521020849_CIT0020","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2007.04.086","article-title":"The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada","volume":"25","author":"Brisson","year":"2007","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521020849_CIT0021","doi-asserted-by":"crossref","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom","volume":"337","author":"Jit","year":"2008","journal-title":"BMJ."},{"issue":"2","key":"key\n\t\t\t\t20170521020849_CIT0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurpub\/ckp141","article-title":"A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme","volume":"20","author":"Dee","year":"2010","journal-title":"Eur J Public Health."},{"key":"key\n\t\t\t\t20170521020849_CIT0023","doi-asserted-by":"crossref","first-page":"d5775","DOI":"10.1136\/bmj.d5775","article-title":"Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model","volume":"343","author":"Jit","year":"2011","journal-title":"BMJ."},{"issue":"3","key":"key\n\t\t\t\t20170521020849_CIT0024","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2011.01.029","article-title":"Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles","volume":"121","author":"Capri","year":"2011","journal-title":"Gynecol Oncol."},{"key":"key\n\t\t\t\t20170521020849_CIT0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2458-11-203","article-title":"Cost-effectiveness of different human papillomavirus vaccines in Singapore","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Public Health."},{"issue":"33","key":"key\n\t\t\t\t20170521020849_CIT0026","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","article-title":"Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis","volume":"28","author":"Van de Velde","year":"2010","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521020849_CIT0027","volume-title":"SEER Summary Staging Manual\u20142000: Codes and Coding Instructions","author":"Young","year":"2001"},{"issue":"48","key":"key\n\t\t\t\t20170521020849_CIT0028","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1016\/j.vaccine.2011.02.091","article-title":"The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia","volume":"29","author":"Smith","year":"2011","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521020849_CIT0029","author":"Malagon"},{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol."},{"issue":"19","key":"key\n\t\t\t\t20170521020849_CIT0031","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t20170521020849_CIT0032"},{"issue":"3","key":"key\n\t\t\t\t20170521020849_CIT0033","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/hv.18865","article-title":"Sustained immunogenicity and efficacy of the HPV-16\/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up","volume":"8","author":"Roteli-Martins","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"key\n\t\t\t\t20170521020849_CIT0034","author":"Statistics Canada","year":"2011"},{"key":"key\n\t\t\t\t20170521020849_CIT0035","volume-title":"Epidemiology of Cervical Abnormalities and Utilization of Related Health Care Resources","author":"Demers","year":"2009"},{"key":"key\n\t\t\t\t20170521020849_CIT0036","volume-title":"Screening for the Cancer of the Cervix: An Office Manual for Health Professionals","author":"BC Cancer Agency","year":"2010","edition":"9th ed"},{"issue":"4","key":"key\n\t\t\t\t20170521020849_CIT0037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1701-2163(16)32441-0","article-title":"Ontario cervical cancer screening clinical practice guidelines","volume":"29","author":"McLachlin","year":"2007","journal-title":"J Obstet Gynaecol Can."},{"key":"key\n\t\t\t\t20170521020849_CIT0038","author":"CancerCare Manitoba","year":"2011"},{"issue":"10","key":"key\n\t\t\t\t20170521020849_CIT0039","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med."},{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol."},{"issue":"2","key":"key\n\t\t\t\t20170521020849_CIT0041","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","article-title":"Number of cervical biopsies and sensitivity of colposcopy","volume":"108","author":"Gage","year":"2006","journal-title":"Obstet Gynecol."},{"issue":"5","key":"key\n\t\t\t\t20170521020849_CIT0042","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajog.2008.12.025","article-title":"Colposcopy to evaluate abnormal cervical cytology in 2008","volume":"200","author":"Chase","year":"2009","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"key\n\t\t\t\t20170521020849_CIT0043","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2303.2003.00082.x","article-title":"Long-term follow-up of patients following negative colposcopy: a new gold standard and its implications for cervical screening","volume":"14","author":"Da Forno","year":"2003","journal-title":"Cytopathology."},{"issue":"12","key":"key\n\t\t\t\t20170521020849_CIT0044","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/PAS.0b013e318058a544","article-title":"Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists","volume":"31","author":"Cai","year":"2007","journal-title":"Am J Surg Pathol."},{"issue":"7","key":"key\n\t\t\t\t20170521020849_CIT0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/aje\/kwk059","article-title":"Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty","volume":"165","author":"Van de Velde","year":"2007","journal-title":"Am J Epidemiol."},{"key":"key\n\t\t\t\t20170521020849_CIT0046","article-title":"The psychosocial impact of an abnormal cervical smear result","author":"Drolet","year":"2011","journal-title":"Psychooncology"},{"issue":"10","key":"key\n\t\t\t\t20170521020849_CIT0047","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/OLQ.0b013e3182215512","article-title":"The impact of anogenital warts on health-related quality of life: a 6-month prospective study","volume":"38","author":"Drolet","year":"2011","journal-title":"Sex Trans Dis"},{"issue":"12","key":"key\n\t\t\t\t20170521020849_CIT0048","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.23459","article-title":"Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia","volume":"122","author":"Ades","year":"2008","journal-title":"Int J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170521020849_CIT0049","first-page":"485","article-title":"The natural history of type-specific human papillomavirus infections in female university students","volume":"12","author":"Richardson","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"3","key":"key\n\t\t\t\t20170521020849_CIT0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ijc.21897","article-title":"Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)","volume":"119","author":"Mayrand","year":"2006","journal-title":"Int J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170521020849_CIT0051","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jmv.22081","article-title":"Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada","volume":"83","author":"Coutlee","year":"2011","journal-title":"J Med Virol."},{"issue":"4","key":"key\n\t\t\t\t20170521020849_CIT0052","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0053","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1525-1438.2001.011001024.x","article-title":"Cervical cancer in Canada: changing patterns in incidence and mortality","volume":"11","author":"Liu","year":"2001","journal-title":"Int J Gynecol Cancer."},{"key":"key\n\t\t\t\t20170521020849_CIT0054","author":"Statistics Canada. Health in Canada\u2014CANSIM tables"},{"key":"key\n\t\t\t\t20170521020849_CIT0055","author":"BC Cancer Agency","year":"2009"},{"key":"key\n\t\t\t\t20170521020849_CIT0056","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1080\/03610928008827996","article-title":"Small sample sensitivity analysis techniques for computer models, with an application to risk assessment","volume":"A9","author":"Iman","year":"1980","journal-title":"Commun Stat Theor Meth."},{"key":"key\n\t\t\t\t20170521020849_CIT0057","first-page":"239","article-title":"A comparison of three methods for selecting values of input variables in the analysis of output from a computer code","volume":"21","author":"McKay","year":"1979","journal-title":"Technometrics."},{"issue":"8","key":"key\n\t\t\t\t20170521020849_CIT0058","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm0895-815","article-title":"The intrinsic transmission dynamics of tuberculosis epidemics","volume":"1","author":"Blower","year":"1995","journal-title":"Nat Med."},{"issue":"2","key":"key\n\t\t\t\t20170521020849_CIT0059","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multiparameter calibration of a natural history model of cervical cancer","volume":"166","author":"Kim","year":"2007","journal-title":"Am J Epidemiol."},{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0272989X09336140","article-title":"Estimating progression rates for human papillomavirus infection from epidemiological data","volume":"30","author":"Jit","year":"2010","journal-title":"Med Decis Making."},{"issue":"12","key":"key\n\t\t\t\t20170521020849_CIT0061","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","article-title":"The known unknowns of HPV natural history","volume":"121","author":"Gravitt","year":"2011","journal-title":"J Clin Invest."},{"issue":"suppl 10","key":"key\n\t\t\t\t20170521020849_CIT0062","doi-asserted-by":"crossref","first-page":"K76","DOI":"10.1016\/j.vaccine.2008.06.009","article-title":"Modeling cervical cancer prevention in developed countries","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine."},{"issue":"5\u20136","key":"key\n\t\t\t\t20170521020849_CIT0063","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000214924","article-title":"Economic evaluation of human papillomavirus vaccination in developed countries","volume":"12","author":"Brisson","year":"2009","journal-title":"Public Health Genomics."},{"issue":"8","key":"key\n\t\t\t\t20170521020849_CIT0064","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","year":"2008","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t20170521020849_CIT0065","author":"Public Health Agency of Canada","year":"2008"},{"issue":"9548","key":"key\n\t\t\t\t20170521020849_CIT0066","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(06)69479-8","article-title":"Sexual behaviour in context: a global perspective","volume":"368","author":"Wellings","year":"2006","journal-title":"Lancet."},{"key":"key\n\t\t\t\t20170521020849_CIT0067","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer [published online ahead of print February 9, 2012]","author":"Guan","year":"2012","journal-title":"Int J Cancer."},{"issue":"1","key":"key\n\t\t\t\t20170521020849_CIT0068","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer."},{"issue":"12","key":"key\n\t\t\t\t20170521020849_CIT0069","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis."},{"key":"key\n\t\t\t\t20170521020849_CIT0070","author":"International Agency for Research in Cancer","year":"2008"},{"key":"key\n\t\t\t\t20170521020849_CIT0071","author":"Adler","year":"2012"},{"issue":"19","key":"key\n\t\t\t\t20170521020849_CIT0072","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.10.029","article-title":"An analytical framework for immunization programs in Canada","volume":"23","author":"Erickson","year":"2005","journal-title":"Vaccine."},{"key":"key\n\t\t\t\t20170521020849_CIT0073","author":"GlaxoSmithKline"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/104\/22\/1712\/17311960\/djs395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T22:06:54Z","timestamp":1562278014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djs395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,27]]},"references-count":73,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2012,10,27]]},"published-print":{"date-parts":[[2012,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djs395","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,27]]}}}